Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

CP-2: a tricyclic pyrone compound in Alzheimer's disease

April 1, 2015

Lu-177-DOTA-girentuximab tested in patients with advanced renal cell carcinoma

April 1, 2015

IMO-8400 as a potential therapy for psoriasis and other immune-mediated inflammatory diseases

April 1, 2015

Ono describes novel peptidic FXIa inhibitors

April 1, 2015

RORgamma inverse agonists with good drug-like properties

April 1, 2015

Novel molecular markers of prostate cancer

April 1, 2015

DRM-01 significantly improves acne in a phase IIa trial

March 31, 2015

Preliminary data presented from phase II GTx-758 study

March 31, 2015

Selective sodium channel blockers identified at Merck & Co.

March 31, 2015

Merck & Co. describes novel IRAK-4 inhibitor with efficacy in inflammation

March 31, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.